Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Nanosphere amends IPO

Nanosphere (Northbrook, Ill.) amended its IPO and hopes to

Read the full 95 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE